Yan Leyfman

959 total citations
25 papers, 338 citations indexed

About

Yan Leyfman is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Yan Leyfman has authored 25 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Yan Leyfman's work include Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Yan Leyfman is often cited by papers focused on Cancer Genomics and Diagnostics (4 papers), CAR-T cell therapy research (3 papers) and COVID-19 Clinical Research Studies (3 papers). Yan Leyfman collaborates with scholars based in United States, Georgia and Italy. Yan Leyfman's co-authors include Jingfang Ju, Yuan Wang, Galina I. Botchkina, James Lee, Luke Kim, Christine Chow, Adil Daud, Michael D. Green, Laura A. Huppert and Howard C. Crawford and has published in prestigious journals such as Blood, Molecular Cancer and Molecular Therapy.

In The Last Decade

Yan Leyfman

24 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yan Leyfman United States 9 195 117 71 61 49 25 338
Teresa J. Melink United States 10 119 0.6× 146 1.2× 102 1.4× 108 1.8× 38 0.8× 24 388
Justin T. Moyers United States 8 254 1.3× 141 1.2× 124 1.7× 37 0.6× 93 1.9× 35 446
Lindsey Carlsen United States 10 127 0.7× 124 1.1× 58 0.8× 48 0.8× 39 0.8× 23 284
Shaocong Wu China 10 199 1.0× 255 2.2× 96 1.4× 130 2.1× 80 1.6× 14 454
Jagdeep Singh India 6 345 1.8× 205 1.8× 128 1.8× 95 1.6× 54 1.1× 18 529
Rochelle Fletcher United States 7 229 1.2× 166 1.4× 177 2.5× 44 0.7× 51 1.0× 10 445
Tai‐Kuang Chao Taiwan 9 200 1.0× 298 2.5× 55 0.8× 112 1.8× 36 0.7× 11 474
Steven M. Schmid United States 11 132 0.7× 194 1.7× 45 0.6× 35 0.6× 39 0.8× 14 389
K. Arnold United States 9 224 1.1× 164 1.4× 95 1.3× 76 1.2× 59 1.2× 23 457

Countries citing papers authored by Yan Leyfman

Since Specialization
Citations

This map shows the geographic impact of Yan Leyfman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Leyfman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Leyfman more than expected).

Fields of papers citing papers by Yan Leyfman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yan Leyfman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Leyfman. The network helps show where Yan Leyfman may publish in the future.

Co-authorship network of co-authors of Yan Leyfman

This figure shows the co-authorship network connecting the top 25 collaborators of Yan Leyfman. A scholar is included among the top collaborators of Yan Leyfman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yan Leyfman. Yan Leyfman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Leyfman, Yan, et al.. (2025). Expanding Horizons in T-Cell Lymphoma Therapy: Focus on Personalized Treatment Strategies. PubMed. 39(3902). 80–84. 1 indexed citations
2.
Park, Chandler H., et al.. (2025). Understanding and treating HPV-associated oropharyngeal carcinoma: insights from a MedNewsWeek Keynote lecture by Dr Theodoros N. Teknos and literature review. Therapeutic Advances in Medical Oncology. 17. 22767026–22767026. 1 indexed citations
3.
4.
Park, Chandler H., et al.. (2024). Reviewing the Landscape of Cancer Survivorship: Insights from Dr. Lidia Schapira’s Programs and Beyond. Cancers. 16(6). 1216–1216. 3 indexed citations
5.
Park, Chandler H., et al.. (2024). Advancing Pancreatic Cancer Surgical Treatments and Proposal of New Approaches. Cancers. 16(16). 2848–2848. 1 indexed citations
6.
7.
Leyfman, Yan, et al.. (2023). Cancer and COVID-19: unravelling the immunological interplay with a review of promising therapies against severe SARS-CoV-2 for cancer patients. Journal of Hematology & Oncology. 16(1). 39–39. 8 indexed citations
8.
Park, Chandler H., et al.. (2023). The Potential of Lifestyle Medicine: Strategies to Optimize Health and Well-Being in Oncology Care with Dr. Amy Comander. Cancers. 15(22). 5323–5323. 1 indexed citations
9.
Leyfman, Yan, et al.. (2023). Extracellular vesicles: A promising therapy against SARS-CoV-2 infection. Molecular Therapy. 31(5). 1196–1200. 3 indexed citations
10.
Utengen, Audun, Deanna J. Attai, Emily K. Drake, et al.. (2022). Social Media and Professional Development for Oncology Professionals. JCO Oncology Practice. 18(8). 566–571. 10 indexed citations
11.
Leyfman, Yan, et al.. (2022). Immunotherapy in Sarcoma. Surgical Oncology Clinics of North America. 31(3). 381–397. 13 indexed citations
12.
Utengen, Audun, Deanna J. Attai, Emily K. Drake, et al.. (2022). Social Media and Professional Development for Oncology Professionals.. PubMed. 18(8). 566–571. 7 indexed citations
13.
Joffe, Erel, Yan Leyfman, Esther Drill, et al.. (2021). Active surveillance of primary extranodal marginal zone lymphoma of bronchus-associated lymphoid tissue. Blood Advances. 5(2). 345–351. 7 indexed citations
14.
Huppert, Laura A., Michael D. Green, Luke Kim, et al.. (2021). Tissue-specific Tregs in cancer metastasis: opportunities for precision immunotherapy. Cellular and Molecular Immunology. 19(1). 33–45. 84 indexed citations
15.
Lyman, Gary H., Aakash Desai, Yan Leyfman, & Nicole M. Kuderer. (2021). Opportunities and Challenges of Observational Studies and Randomized Controlled Trials for Evaluating the Therapeutic Efficacy of COVID-19 Convalescent Plasma. Cancer Investigation. 39(6-7). 449–456. 1 indexed citations
16.
Leyfman, Yan, Sagar Galwankar, Prabath W.B. Nanayakkara, et al.. (2020). Potential Immunotherapeutic Targets for Hypoxia Due to COVI-Flu. Shock. 54(4). 438–450. 16 indexed citations
17.
18.
Leyfman, Yan. (2018). Chimeric antigen receptors: unleashing a new age of anti-cancer therapy. Cancer Cell International. 18(1). 182–182. 11 indexed citations
19.
Botchkina, Galina I., Edison S. Zuniga, Manisha Das, et al.. (2010). New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells. Molecular Cancer. 9(1). 192–192. 66 indexed citations
20.
Botchkina, Inna L., David E. Rivadeneira, Martin S. Karpeh, et al.. (2009). Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.. PubMed. 6(1). 19–29. 88 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Teresa J. Melink Breakdown of academic impact, for papers by Justin T. Moyers Breakdown of academic impact, for papers by Lindsey Carlsen Breakdown of academic impact, for papers by Shaocong Wu Breakdown of academic impact, for papers by Jagdeep Singh Breakdown of academic impact, for papers by Rochelle Fletcher Breakdown of academic impact, for papers by Tai‐Kuang Chao Breakdown of academic impact, for papers by Steven M. Schmid Breakdown of academic impact, for papers by K. Arnold
Rankless by CCL
2026